KLK4 and neoplasm: To determine the clinical utility of the kallikrein family as potential tumour markers for colorectal cancer, the expression profile of several members of the family was examined by immunofluorometric ELISA assays, previously developed and validated (Dorn et al, 2007; Shaw and Diamandis, 2007; Planque et al, 2008).